{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:24:49Z","timestamp":1790418289508,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/leu.2016.80","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T06:41:47Z","timestamp":1461307307000},"page":"1824-1831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The role of the RAS pathway in iAMP21-ALL"],"prefix":"10.1038","volume":"30","author":[{"given":"S L","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Grossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Towers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Partington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Minto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Keavney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Bown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Santibanez-Koref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A V","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A E","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"BFleu201680_CR1","volume-title":"Acute Lymphoblastic Leukemia","author":"CJ Harrison","year":"2009","unstructured":"Harrison CJ, Johansson B . Acute Lymphoblastic Leukemia. 3rd edn. Wiley-Blackwell: New Jersey, USA, 2009."},{"key":"BFleu201680_CR2","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758\u2013764.","journal-title":"Nature"},{"key":"BFleu201680_CR3","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","volume":"118","author":"J Zhang","year":"2011","unstructured":"Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, Edmonson M et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2011; 118: 3080\u20133087.","journal-title":"Blood"},{"key":"BFleu201680_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.2532","volume":"45","author":"L Holmfeldt","year":"2013","unstructured":"Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet 2013; 45: 242\u2013252.","journal-title":"Nat Genet"},{"key":"BFleu201680_CR5","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1158\/0008-5472.CAN-08-0101","volume":"68","author":"M Case","year":"2008","unstructured":"Case M, Matheson E, Minto L, Hassan R, Harrison CJ, Bown N et al. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia. Cancer Res 2008; 68: 6803\u20136809.","journal-title":"Cancer Res"},{"key":"BFleu201680_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","volume":"22","author":"G Roberts Kathryn","year":"2012","unstructured":"Roberts Kathryn G, Morin Ryan D, Zhang J, Hirst M, Zhao Y, Su X et al. Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia. Cancer Cell 2012; 22: 153\u2013166.","journal-title":"Cancer Cell"},{"key":"BFleu201680_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/leu.2013.277","volume":"28","author":"E Clappier","year":"2014","unstructured":"Clappier E, Auclerc MF, Rapion J, Bakkus M, Caye A, Khemiri et al. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. Leukemia 2014; 28: 70\u201377.","journal-title":"Leukemia"},{"key":"BFleu201680_CR8","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1182\/blood-2014-04-531871","volume":"124","author":"J Irving","year":"2014","unstructured":"Irving J, Matheson E, Minto L, Blair H, Case M, Halsey C et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood 2014; 124: 3420\u20133430.","journal-title":"Blood"},{"key":"BFleu201680_CR9","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 2014; 371: 1005\u20131015.","journal-title":"N Engl J Med"},{"key":"BFleu201680_CR10","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1200\/JCO.2012.47.6770","volume":"31","author":"BW Weston","year":"2013","unstructured":"Weston BW, Hayden MA, Roberts KG, Bowyer S, Hsu J, Fedoriw G et al. Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia. J Clin Oncol 2013; 31: e413\u2013e416.","journal-title":"J Clin Oncol"},{"key":"BFleu201680_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","volume":"11","author":"AV Moorman","year":"2010","unstructured":"Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, Kinsey SE et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial. Lancet Oncol 2010; 11: 429\u2013438.","journal-title":"Lancet Oncol"},{"key":"BFleu201680_CR12","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1200\/JCO.2013.48.9377","volume":"31","author":"AV Moorman","year":"2013","unstructured":"Moorman AV, Robinson H, Schwab C, Richards SM, Hancock J, Mitchell CD et al. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97\/99 and UKALL2003 trials. J Clin Oncol 2013; 31: 3389\u20133396.","journal-title":"J Clin Oncol"},{"key":"BFleu201680_CR13","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1200\/JCO.2013.49.1308","volume":"31","author":"NA Heerema","year":"2013","unstructured":"Heerema NA, Carroll AJ, Devidas M, Loh ML, Borowitz MJ, Gastier-Foster JM et al. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group. J Clin Oncol 2013; 31: 3397\u20133402.","journal-title":"J Clin Oncol"},{"key":"BFleu201680_CR14","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/leu.2013.317","volume":"28","author":"CJ Harrison","year":"2014","unstructured":"Harrison CJ, Moorman AV, Schwab C, Carroll AJ, Raetz EA, Devidas M et al. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Leukemia 2014; 28: 1015\u20131021.","journal-title":"Leukemia"},{"key":"BFleu201680_CR15","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1200\/JCO.2008.16.1117","volume":"26","author":"A Attarbaschi","year":"2008","unstructured":"Attarbaschi A, Mann G, Panzer-Grumayer R, Rottgers S, Steiner M, Konig M et al. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. J Clin Oncol 2008; 26: 3046\u20133050.","journal-title":"J Clin Oncol"},{"key":"BFleu201680_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature13115","volume":"508","author":"Y Li","year":"2014","unstructured":"Li Y, Schwab C, Ryan SL, Papaemmanuil E, Robinson HM, Jacobs P et al. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature 2014; 508: 98\u2013102.","journal-title":"Nature"},{"key":"BFleu201680_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1365-2141.2005.05497.x","volume":"129","author":"CJ Harrison","year":"2005","unstructured":"Harrison CJ, Moorman AV, Barber KE, Broadfield ZJ, Cheung KL, Harris RL et al. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. Br J Haematol 2005; 129: 520\u2013530.","journal-title":"Br J Haematol"},{"key":"BFleu201680_CR18","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3324\/haematol.2013.085175","volume":"98","author":"CJ Schwab","year":"2013","unstructured":"Schwab CJ, Chilton L, Morrison H, Jones L, Al-Shehhi H, Erhorn et al. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. Haematologica 2013; 98: 1081\u20131088.","journal-title":"Haematologica"},{"key":"BFleu201680_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/emmm.201201703","volume":"5","author":"K Rehe","year":"2013","unstructured":"Rehe K, Wilson K, Bomken S, Williamson D, Irving J, den Boer ML et al. Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations. EMBO Mol Med 2013; 5: 38\u201351.","journal-title":"EMBO Mol Med"},{"key":"BFleu201680_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.gde.2013.11.014","volume":"24","author":"LB Alexandrov","year":"2014","unstructured":"Alexandrov LB, Stratton MR . Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev 2014; 24: 52\u201360.","journal-title":"Curr Opin Genet Dev"},{"key":"BFleu201680_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV et al. Signatures of mutational processes in human cancer. Nature 2013; 500: 415\u2013421.","journal-title":"Nature"},{"key":"BFleu201680_CR22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ejhg.2011.37","volume":"19","author":"MC Jongmans","year":"2011","unstructured":"Jongmans MC, van der Burgt I, Hoogerbrugge PM, Noordam K, Yntema HG, Nillesen WM et al. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet 2011; 19: 870\u2013874.","journal-title":"Eur J Hum Genet"},{"key":"BFleu201680_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/gcc.20502","volume":"47","author":"K Paulsson","year":"2008","unstructured":"Paulsson K, Horvat A, Strombeck B, Nilsson F, Heldrup J, Behrendtz M et al. Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2008; 47: 26\u201333.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu201680_CR24","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/leu.2015.107","volume":"29","author":"K Malinowska-Ozdowy","year":"2015","unstructured":"Malinowska-Ozdowy K, Frech C, Schonegger A, Eckert C, Cazzaniga G, Stanulla M et al. KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia. Leukemia 2015; 29: 1656\u20131667.","journal-title":"Leukemia"},{"key":"BFleu201680_CR25","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.1182\/blood-2011-01-329961","volume":"117","author":"V Rand","year":"2011","unstructured":"Rand V, Parker H, Russell LJ, Schwab C, Ensor H, Irving J et al. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia. Blood 2011; 117: 6848\u20136855.","journal-title":"Blood"},{"key":"BFleu201680_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrclinonc.2014.83","volume":"11","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Adjei AA . The clinical development of MEK inhibitors. Nat Rev Clin Oncol 2014; 11: 385\u2013400.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFleu201680_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ng.3301","volume":"47","author":"K Paulsson","year":"2015","unstructured":"Paulsson K, Lilljebjorn H, Biloglav A, Olsson L, Rissler M, Castor et al. The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Nat Genet 2015; 47: 672\u2013676.","journal-title":"Nat Genet"},{"key":"BFleu201680_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ng.2874","volume":"46","author":"E Papaemmanuil","year":"2014","unstructured":"Papaemmanuil E, Rapado I, Li Y, Potter NE, Wedge DC, Tubio J et al. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet 2014; 46: 116\u2013125.","journal-title":"Nat Genet"},{"key":"BFleu201680_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ng.3230","volume":"47","author":"AK Andersson","year":"2015","unstructured":"Andersson AK, Ma J, Wang J, Chen X, Gedman AL, Dang J et al. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat Genet 2015; 47: 330\u2013337.","journal-title":"Nat Genet"},{"key":"BFleu201680_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/humu.22719","volume":"36","author":"CM Lindqvist","year":"2015","unstructured":"Lindqvist CM, Nordlund J, Ekman D, Johansson A, Moghadam BT, Raine et al. The mutational landscape in pediatric acute lymphoblastic leukemia deciphered by whole genome sequencing. Hum Mutat 2015; 36: 118\u2013128.","journal-title":"Hum Mutat"},{"key":"BFleu201680_CR31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/leu.2014.13","volume":"28","author":"L Melchor","year":"2014","unstructured":"Melchor L, Brioli A, Wardell CP, Murison A, Potter NE, Kaiser MF et al. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma. Leukemia 2014; 28: 1705\u20131715.","journal-title":"Leukemia"},{"key":"BFleu201680_CR32","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1038\/ncomms7604","volume":"6","author":"X Ma","year":"2015","unstructured":"Ma X, Edmonson M, Yergeau D, Muzny DM, Hampton OA, Rusch M et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun 2015; 6: 6604.","journal-title":"Nat Commun"},{"key":"BFleu201680_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502: 333\u2013339.","journal-title":"Nature"},{"key":"BFleu201680_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.drup.2009.04.001","volume":"12","author":"E Weisberg","year":"2009","unstructured":"Weisberg E, Barrett R, Liu Q, Stone R, Gray N, Griffin JD . FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML. Drug Resist Updat 2009; 12: 81\u201389.","journal-title":"Drug Resist Updat"},{"key":"BFleu201680_CR35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1182\/blood-2006-05-024018","volume":"110","author":"C Choudhary","year":"2007","unstructured":"Choudhary C, Brandts C, Schwable J, Tickenbrock L, Sargin B, Ueker et al. Activation mechanisms of STAT5 by oncogenic Flt3-ITD. Blood 2007; 110: 370\u2013374.","journal-title":"Blood"},{"key":"BFleu201680_CR36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc4000","volume":"15","author":"CJ Caunt","year":"2015","unstructured":"Caunt CJ, Sale MJ, Smith PD, Cook SJ . MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road. Nat Rev Cancer 2015; 15: 577\u2013592.","journal-title":"Nat Rev Cancer"},{"key":"BFleu201680_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/hmg\/dds426","volume":"22","author":"IC Cirstea","year":"2013","unstructured":"Cirstea IC, Gremer L, Dvorsky R, Zhang SC, Piekorz RP, Zenker M et al. Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes. Hum Mol Genet 2013; 22: 262\u2013270.","journal-title":"Hum Mol Genet"},{"key":"BFleu201680_CR38","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1182\/blood-2004-11-4430","volume":"105","author":"R Grundler","year":"2005","unstructured":"Grundler R, Miething C, Thiede C, Peschel C, Duyster J . FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model. Blood 2005; 105: 4792\u20134799.","journal-title":"Blood"},{"key":"BFleu201680_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/aging.100296","volume":"3","author":"LS Steelman","year":"2011","unstructured":"Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P et al. Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging 2011; 3: 192\u2013222.","journal-title":"Aging"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu201680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu201680","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu201680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:06:59Z","timestamp":1684433219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFleu201680"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.80","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]},"assertion":[{"value":"9 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}